HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The hemodynamic effects of landiolol, an ultra-short-acting beta1-selective blocker, on endotracheal intubation in patients with and without hypertension.

AbstractBACKGROUND:
The ultra-short-acting beta1-selective blocker, landiolol, is widely used in Japan. We investigated the effects of landiolol on intubation-induced adrenergic response in 88 patients.
METHODS:
General anesthesia was induced and maintained with target-controlled infusion of propofol at an effect-site concentration of 5 microg/mL. Muscle relaxation was obtained with 0.1 mg/kg vecuronium, and endotracheal intubation was performed 4 min after vecuronium injection. We first investigated the optimal time point for landiolol to be administered before intubation in 43 normotensive patients. Then we examined whether landiolol was as effective as fentanyl to prevent tachycardia after intubation in 45 hypertensive patients.
RESULTS:
Landiolol at 0.1 mg/kg was most effective against intubation-induced tachycardia when infused 4 min before intubation in normotensive patients. However, 0.2 mg/kg landiolol was necessary to prevent tachycardia after intubation in hypertensive patients. Landiolol had no significant effects on arterial blood pressure or bispectral index at any dose throughout the study period. In contrast, 2 mug/kg fentanyl frequently caused hypotension just before and 5 min after intubation.
CONCLUSION:
Low doses of landiolol can effectively prevent tachycardia after intubation without significant effects on arterial blood pressure.
AuthorsSoichiro Sugiura, Sumihiko Seki, Kohji Hidaka, Miharu Masuoka, Hideaki Tsuchida
JournalAnesthesia and analgesia (Anesth Analg) Vol. 104 Issue 1 Pg. 124-9 (Jan 2007) ISSN: 1526-7598 [Electronic] United States
PMID17179256 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Adrenergic beta-Antagonists
  • Morpholines
  • Receptors, Adrenergic, beta-1
  • landiolol
  • Urea
  • Fentanyl
Topics
  • Adrenergic beta-Antagonists (therapeutic use)
  • Adult
  • Aged
  • Arthroplasty, Replacement, Hip
  • Blood Pressure (drug effects)
  • Female
  • Fentanyl (pharmacology)
  • Heart Rate (drug effects)
  • Humans
  • Hypertension (physiopathology)
  • Hypotension (chemically induced)
  • Intubation, Intratracheal
  • Male
  • Middle Aged
  • Morpholines (therapeutic use)
  • Receptors, Adrenergic, beta-1 (drug effects, physiology)
  • Tachycardia (prevention & control)
  • Urea (analogs & derivatives, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: